Latest Asx News

Astral Resources has secured a fully-funded joint venture with Mineral Mining Services to accelerate early gold production at its Think Big Gold Project near Kalgoorlie, promising reduced funding risks and faster cash flow.

Vection Technologies has secured $1.5 million in AI-driven enterprise orders spanning agritech, cybersecurity, real estate, healthcare, and public administration, reinforcing its recurring revenue model and cross-sector appeal.

GoldArc Resources has revealed extraordinary high-grade gold mineralisation in historical data from the Cosmopolitan Gold Mine, opening new prospects for resource expansion. The company plans targeted drilling to validate these findings and define a JORC-compliant resource.

Aquirian Limited has secured a $2.3 million strategic placement with Topgroup and signed a non-binding Memorandum of Understanding to form Drillforce WA, a 50 – 50 joint venture combining their drilling and blasting expertise.

Auravelle Metals has identified a significant 10-kilometre zone of gold and silver anomalies at its Nuckulla Hill project in South Australia, setting the stage for an active drilling campaign and further exploration in 2026.

Infini Resources is fast-tracking exploration at its Reynolds and Reitenbach Lake uranium projects following the identification of visible uraninite and multiple radiometric anomalies, signaling promising potential in Saskatchewan’s Athabasca Basin.

Rox Resources has reported significant progress at its Youanmi Gold Project, including a 36% increase in underground gold resources and on-track completion of its Definitive Feasibility Study, setting the stage for production in Western Australia.

Turners Automotive Group has updated its dividend announcement, revealing a fully franked ordinary dividend and detailing the strike price for its Dividend Reinvestment Plan.

Vectus Biosystems has had its ASX trading suspension lifted following the disclosure of a significant transaction involving a compound from its drug library, signaling renewed investor interest.

Vectus Biosystems has agreed to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics for US$3 million in shares and warrants, gaining a strategic equity position while refocusing on its cardiovascular and fibrosis pipeline.

Shriro Holdings announces a $5 million off-market share buy-back at a 14.1% premium, signaling a pivot from acquisitions to expanding its BBQ range globally. The move aims to return excess capital to shareholders while maintaining flexibility for further buy-backs.

DGL Group Limited remains suspended from ASX trading following delays in lodging audited accounts and a concerning auditor disclaimer. Investors await clarity on the company’s financial health and path to reinstatement.